KARYOPHARM THERAPEUTICS INC's ticker is KPTI and the CUSIP is 48576U106. A total of 141 filers reported holding KARYOPHARM THERAPEUTICS INC in Q1 2022. The put-call ratio across all filers is 0.42 and the average weighting 0.1%.
Quarter-by-quarter ownership
| Value | Shares | Weighting | ||||
|---|---|---|---|---|---|---|
| Q3 2022 | $66,000 | +17.9% | 12,012 | -2.7% | 0.00% | – |
| Q2 2022 | $56,000 | -41.1% | 12,341 | -3.8% | 0.00% | – |
| Q1 2022 | $95,000 | -11.2% | 12,833 | -23.1% | 0.00% | – |
| Q4 2021 | $107,000 | +5.9% | 16,684 | -3.6% | 0.00% | – |
| Q3 2021 | $101,000 | -56.5% | 17,314 | -22.9% | 0.00% | -100.0% |
| Q2 2021 | $232,000 | +24.7% | 22,451 | +27.2% | 0.00% | 0.0% |
| Q1 2021 | $186,000 | -33.3% | 17,651 | -2.0% | 0.00% | 0.0% |
| Q4 2020 | $279,000 | -12.8% | 18,011 | -17.7% | 0.00% | 0.0% |
| Q3 2020 | $320,000 | +13.5% | 21,886 | +47.1% | 0.00% | 0.0% |
| Q2 2020 | $282,000 | +19.5% | 14,881 | +21.0% | 0.00% | 0.0% |
| Q1 2020 | $236,000 | – | 12,295 | – | 0.00% | – |
Download | ||||||
Other shareholders
| Name | Shares | Value | Weighting ↓ |
|---|---|---|---|
| Consonance Capital Management LP | 4,767,078 | $80,993,000 | 5.22% |
| Palo Alto Investors LP | 4,663,324 | $79,230,000 | 3.17% |
| DOHENY ASSET MANAGEMENT /CA | 282,945 | $4,807,000 | 2.61% |
| Private Capital Advisors, Inc. | 416,900 | $7,083,000 | 2.22% |
| Sandia Holdings, LLC | 119,739 | $2,034,000 | 0.91% |
| Virtus ETF Advisers LLC | 44,986 | $764,000 | 0.68% |
| Birchview Capital, LP | 50,000 | $850,000 | 0.58% |
| Schonfeld Strategic Advisors LLC | 415,600 | $7,061,000 | 0.38% |
| EMERALD ADVISERS, LLC | 561,317 | $9,537,000 | 0.36% |
| Kazazian Asset Management, LLC | 20,672 | $351,000 | 0.32% |